Michael Sweeney
Vermogen: 10 406 $ op 30-06-2026
Vermogen: 10 406 $ op 30-06-2026
Dr. Michael T.
Sweeney, MD, is a Senior Vice President-Clinical Development at Resverlogix Corp.
Dr. Sweeney was previously employed as a Chief Medical Officer, VP-Research & Development by Depomed, Inc., a Vice President-Medical Affairs by CV Therapeutics, Inc., a Senior Director-Urology Global Medial Group Leader by Pfizer Inc., and a Senior Clinical Pharmacologist by Zeneca Group Plc.
He received his doctorate degree from The University of Liverpool.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RESVERLOGIX CORP. 0,05% | 02-04-2025 | 155.312 ( 0,05% ) | 10 406 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RESVERLOGIX CORP. | Hoofd Techniek/Wetenschap/O&O | 03-11-2014 |
| Bedrijven | Functie | Einde |
|---|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Hoofd Techniek/Wetenschap/O&O | 01-09-2007 |
| PFIZER INC. | Corporate Officer/Principal | 01-01-2003 |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Resverlogix Corp.
Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau